Toronto, ON – The Prostate Cancer Research Foundation of Canada has awarded over $1.2 million to Canadian researchers actively investigating the causes, cure, treatment, and prevention of prostate cancer.
“The foundation is thrilled that we can support the brightest prostate cancer researchers across this country,” says John Blanchard, the foundation’s president & CEO. “Prostate cancer is the number one cancer threat to Canadian men, and research into improving the diagnosis, treatment, and prevention of the disease is grossly under-funded. It requires more attention from the scientific community and the public at large, and this funding will help raise its profile and make further inroads into our understanding of prostate cancer.”
The grantees are primarily focussing on understanding for the risk factors for disease progression and establishing markers to assess them; improving standard therapies for better cure rates; and developing better treatment for hormone-resistant cancer.
McGill University, BC Cancer Agency and Toronto’s Princess Margaret Hospital are three of the research institutions that will receive the grants.